Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

North America Radiotherapy Market - Industry Trends and Forecast To 2027

Published by Data Bridge Market Research Private Limited Product code 961963
Published Content info 90 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Radiotherapy Market - Industry Trends and Forecast To 2027
Published: August 1, 2020 Content info: 90 Pages
Description

North America radiotherapy market is projected to register a CAGR of 5.9% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

North America Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals and Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the North America radiotherapy market are:

Increasing demand of radiotherapy treatment among the cancer patients.

Increasing adoption of non-surgical treatment procedure.

Market Players:

The key market players for North America radiotherapy market are listed below:

Varian Medical Systems, Inc.

ProTom International

Mevion Medical Systems

VIEWRAY TECHNOLOGIES, INC. (A Subsidiary of ViewRay)

Siemens Healthcare GmbH

Elekta AB

Accuray Incorporated

IBA Worldwide

Eckert & Ziegler BEBIG

RaySearch Laboratories

Brainlab AG

Koninklijke Philips N.V.

GE Healthcare

Hitachi, Ltd.

Advanced Accelerator Applications (A Subsidiary of Novartis AG)

Provision Healthcare.

Nordion (Canada) Inc.

Sumitomo Heavy Industries, Ltd.

CIVCO Radiotherapy (A Subsidiary of Roper Technologies)

Isoray Inc

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF NORTH AMERICA RADIOTHERAPY MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TYPE LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NORTH AMERICA RADIOTHERAPY MARKET, MARKET SHARE ANALYSIS
    • 4.1.1 MARKET SHARE ANALYSIS: NORTH AMERICA
    • 4.1.2 MARKET SHARE ANALYSIS: NORTH AMERICA
      • 4.1.2.1 MARKET SHARE ANALYSIS: U.S.
      • 4.1.2.2 MARKET SHARE ANALYSIS: CANADA
      • 4.1.2.3 MARKET SHARE ANALYSIS: MEXICO
    • 4.1.3 MARKET SHARE ANALYSIS: EUROPE
      • 4.1.3.1 MARKET SHARE ANALYSIS: GERMANY
      • 4.1.3.2 MARKET SHARE ANALYSIS: FRANCE
      • 4.1.3.3 MARKET SHARE ANALYSIS: ITALY
      • 4.1.3.4 MARKET SHARE ANALYSIS: U.K.
      • 4.1.3.5 MARKET SHARE ANALYSIS: SPAIN
      • 4.1.3.6 MARKET SHARE ANALYSIS: RUSSIA
      • 4.1.3.7 MARKET SHARE ANALYSIS: NETHERLANDS
      • 4.1.3.8 MARKET SHARE ANALYSIS: SWITZERLAND
      • 4.1.3.9 MARKET SHARE ANALYSIS: BELGIUM
      • 4.1.3.10 MARKET SHARE ANALYSIS: TURKEY
      • 4.1.3.11 MARKET SHARE ANALYSIS: UKRAINE
    • 4.1.4 MARKET SHARE ANALYSIS: ASIA-PACIFIC
      • 4.1.4.1 MARKET SHARE ANALYSIS: CHINA
      • 4.1.4.2 MARKET SHARE ANALYSIS: JAPAN
      • 4.1.4.3 MARKET SHARE ANALYSIS: INDIA
      • 4.1.4.4 MARKET SHARE ANALYSIS: AUSTRALIA
      • 4.1.4.5 MARKET SHARE ANALYSIS: SOUTH KOREA
      • 4.1.4.6 MARKET SHARE ANALYSIS: INDONESIA
      • 4.1.4.7 MARKET SHARE ANALYSIS: THAILAND
      • 4.1.4.8 MARKET SHARE ANALYSIS: SINGAPORE
      • 4.1.4.9 MARKET SHARE ANALYSIS: MALAYSIA
      • 4.1.4.10 MARKET SHARE ANALYSIS: PHILIPPINES
    • 4.1.5 MARKET SHARE ANALYSIS: SOUTH AMERICA
      • 4.1.5.1 MARKET SHARE ANALYSIS: BRAZIL
      • 4.1.5.2 MARKET SHARE ANALYSIS: ARGENTINA
      • 4.1.5.3 MARKET SHARE ANALYSIS: CHILE
    • 4.1.6 MARKET SHARE ANALYSIS: MIDDLE EAST AND AFRICA
      • 4.1.6.1 MARKET SHARE ANALYSIS: SOUTH AFRICA
      • 4.1.6.2 MARKET SHARE ANALYSIS: SAUDI ARABIA
      • 4.1.6.3 MARKET SHARE ANALYSIS: UAE
      • 4.1.6.4 MARKET SHARE ANALYSIS: EGYPT
      • 4.1.6.5 MARKET SHARE ANALYSIS: ISRAEL
  • 4.2 NORTH AMERICA PROTON BEAM THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.2.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
    • 4.2.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.2.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.2.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.2.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.2.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.2.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.2.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.2.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.2.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.2.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.2.4.1 company share analysis: CHINA
      • 4.2.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.2.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.2.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.3 NORTH AMERICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.3.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
    • 4.3.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.3.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.3.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.3.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.3.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.3.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.3.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.3.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.3.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.3.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.3.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.3.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.3.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.3.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.4 NORTH AMERICA IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.4.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
    • 4.4.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.4.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.4.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.4.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.4.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.4.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.4.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.4.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.4.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.4.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.4.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.4.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.4.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.4.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.5 NORTH AMERICA STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.5.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
    • 4.5.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.5.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.5.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.5.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.5.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.5.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.5.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.5.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.5.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.5.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.5.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.5.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.5.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.5.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA

5 IMPACT OF COVID-19 ON NORTH AMERICA RADIOTHERAPY MARKET

  • 5.1 IMPACT ANALYSIS ON DEMAND
  • 5.2 CONCLUSION

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 GROWING PREVALENCE OF CANCER DISEASE
    • 6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT
    • 6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
    • 6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
  • 6.2 RESTRAINTS
    • 6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    • 6.2.2 COMPLEX NATURE OF RADIOTHERAPY
    • 6.2.3 HIGH COST OF RADIOTHERAPY PROCEDURES
  • 6.3 OPPORTUNITIES
    • 6.3.1 INCREASING HEALTHCARE EXPENDITURES FOR CANCER TREATMENTS
    • 6.3.2 GROWING GOVERNMENT INITIATIVES TOWARDS CANCER TREATMENT
    • 6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
  • 6.4 CHALLENGES
    • 6.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
    • 6.4.2 RISK OF RADIATION EXPOSURE

7 NORTH AMERICA RADIOTHERAPY MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 EXTERNAL-BEAM RADIATION THERAPY
    • 7.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
    • 7.2.2 PROTON BEAM THERAPY
    • 7.2.3 STEREOTACTIC RADIATION THERAPY
    • 7.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
    • 7.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
    • 7.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
    • 7.2.7 OTHERS
  • 7.3 INTERNAL RADIATION THERAPY
    • 7.3.1 BRACHYTHERAPY
    • 7.3.2 SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
    • 7.3.3 BRACHYTHERAPY
      • 7.3.3.1 HIGH DOSE BRACHYTHERAPY
      • 7.3.3.2 LOW DOSE BRACHYTHERAPY
  • 7.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
  • 7.5 OTHERS

8 NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT

  • 8.1 OVERVIEW
  • 8.2 EXTERNAL BEAM RADIOTHERAPY
    • 8.2.1 LINAC
    • 8.2.2 PROTON THERAPY
    • 8.2.3 CYBER KNIFE
    • 8.2.4 GAMMA KNIFE
    • 8.2.5 OTHERS
  • 8.3 INTERNAL RADIOTHERAPY PRODUCTS
    • 8.3.1 SEEDS
    • 8.3.2 AFTERLOADERS
    • 8.3.3 OTHERS
  • 8.4 RADIOTHERAPY SOFTWARE
    • 8.4.1 IMAGE GUIDING SOFTWARE
    • 8.4.2 TREATMENT PLANNING SOFTWARE
    • 8.4.3 PATIENT POSITIONING SOFTWARE
    • 8.4.4 DOSAGE PLANNING SOFTWARE
    • 8.4.5 OTHERS

9 NORTH AMERICA RADIOTHERAPY MARKET, BY APPLICATION

  • 9.1 OVERVIEW
  • 9.2 BREAST CANCER
  • 9.3 LUNG CANCER
  • 9.4 PROSTATE CANCER
  • 9.5 COLORECTAL CANCER
  • 9.6 LYMPHOMA
  • 9.7 LIVER CANCER
  • 9.8 THYROID CANCER
  • 9.9 BRAIN CANCER
  • 9.10 CERVICAL CANCER
  • 9.11 SPINE CANCER
  • 9.12 OTHERS

10 NORTH AMERICA RADIOTHERAPY MARKET, BY END USER

  • 10.1 OVERVIEW
  • 10.2 HOSPITALS
  • 10.3 RADIATION THERAPY CENTERS
  • 10.4 SPECIALTY CLINICS
  • 10.5 OTHERS

11 NORTH AMERICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL

  • 11.1 OVERVIEW
  • 11.2 DIRECT TENDER
  • 11.3 RETAIL SALES
  • 11.4 OTHERS

12 NORTH AMERICA RADIOTHERAPY MARKET, BY GEOGRAPHY

  • 12.1 NORTH AMERICA
    • 12.1.1 U.S.
    • 12.1.2 CANADA
    • 12.1.3 MEXICO

13 NORTH AMERICA RADIOTHERAPY MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

  • 15.1 VARIAN MEDICAL SYSTEMS, INC.
    • 15.1.1 COMPANY SNAPSHOT
    • 15.1.2 REVENUE ANALYSIS
    • 15.1.3 COMPANY SHARE ANALYSIS
    • 15.1.4 PRODUCT PORTFOLIO
    • 15.1.5 RECENT DEVELOPMENTS
  • 15.2 ELEKTA AB
    • 15.2.1 COMPANY SNAPSHOT
    • 15.2.2 REVENUE ANALYSIS
    • 15.2.3 COMPANY SHARE ANALYSIS
    • 15.2.4 PRODUCT PORTFOLIO
    • 15.2.5 RECENT DEVELOPMENTS
  • 15.3 SIEMENS HEALTHCARE GMBH
    • 15.3.1 COMPANY SNAPSHOT
    • 15.3.2 REVENUE ANALYSIS
    • 15.3.3 COMPANY SHARE ANALYSIS
    • 15.3.4 PRODUCT PORTFOLIO
    • 15.3.5 RECENT DEVELOPMENTS
  • 15.4 GE HEALTHCARE
    • 15.4.1 COMPANY SNAPSHOT
    • 15.4.2 REVENUE ANALYSIS
    • 15.4.3 COMPANY SHARE ANALYSIS
    • 15.4.4 PRODUCT PORTFOLIO
    • 15.4.5 RECENT DEVELOPMENT
  • 15.5 ACCURAY INCORPORATED
    • 15.5.1 COMPANY SNAPSHOT
    • 15.5.2 REVENUE ANALYSIS
    • 15.5.3 COMPANY SHARE ANALYSIS
    • 15.5.4 PRODUCT PORTFOLIO
    • 15.5.5 RECENT DEVELOPMENT
  • 15.6 KONINKLIJKE PHILIPS N.V.
    • 15.6.1 COMPANY SNAPSHOT
    • 15.6.2 REVENUE ANALYSIS
    • 15.6.3 PRODUCT PORTFOLIO
    • 15.6.4 RECENT DEVELOPMENTS
  • 15.7 ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG)
    • 15.7.1 COMPANY SNAPSHOT
    • 15.7.2 REVENUE ANALYSIS
    • 15.7.3 PRODUCT PORTFOLIO
    • 15.7.4 RECENT DEVELOPMENT
  • 15.8 BRAINLAB AG
    • 15.8.1 COMPANY SNAPSHOT
    • 15.8.2 PRODUCT PORTFOLIO
    • 15.8.3 RECENT DEVELOPMENT
  • 15.9 CIVCO RADIOTHERAPY (A SUBSIDIARY OF ROPER TECHNOLOGIES, INC.)
    • 15.9.1 COMPANY SNAPSHOT
    • 15.9.2 REVENUE ANALYSIS
    • 15.9.3 PRODUCT PORTFOLIO
    • 15.9.4 RECENT DEVELOPMENT
  • 15.10 ECKERT & ZIEGLER BEBIG
    • 15.10.1 COMPANY SNAPSHOT
    • 15.10.2 REVENUE ANALYSIS
    • 15.10.3 PRODUCT PORTFOLIO
    • 15.10.4 RECENT DEVELOPMENT
  • 15.11 HITACHI, LTD.
    • 15.11.1 COMPANY SNAPSHOT
    • 15.11.2 REVENUE ANALYSIS
    • 15.11.3 PRODUCT PORTFOLIO
    • 15.11.4 RECENT DEVELOPMENT
  • 15.12 IBA WORLDWIDE
    • 15.12.1 COMPANY SNAPSHOT
    • 15.12.2 REVENUE ANALYSIS
    • 15.12.3 PRODUCT PORTFOLIO
    • 15.12.4 RECENT DEVELOPMENT
  • 15.13 ISORAY INC.
    • 15.13.1 COMPANY SNAPSHOT
    • 15.13.2 REVENUE ANALYSIS
    • 15.13.3 PRODUCT PORTFOLIO
    • 15.13.4 RECENT DEVELOPMENT
  • 15.14 MEVION MEDICAL SYSTEMS
    • 15.14.1 COMPANY SNAPSHOT
    • 15.14.2 PRODUCT PORTFOLIO
    • 15.14.3 RECENT DEVELOPMENT
  • 15.15 NORDION (CANADA) INC.
    • 15.15.1 COMPANY SNAPSHOT
    • 15.15.2 PRODUCT PORTFOLIO
    • 15.15.3 RECENT DEVELOPMENT
  • 15.16 PROTOM INTERNATIONAL
    • 15.16.1 COMPANY SNAPSHOT
    • 15.16.2 PRODUCT PORTFOLIO
    • 15.16.3 RECENT DEVELOPMENT
  • 15.17 PROVISION HEALTHCARE
    • 15.17.1 COMPANY SNAPSHOT
    • 15.17.2 SOLUTION PORTFOLIO
    • 15.17.3 RECENT DEVELOPMENT
  • 15.18 RAYSEARCH LABORATORIES
    • 15.18.1 COMPANY SNAPSHOT
    • 15.18.2 REVENUE ANALYSIS
    • 15.18.3 PRODUCT PORTFOLIO
    • 15.18.4 RECENT DEVELOPMENT
  • 15.19 SUMITOMO HEAVY INDUSTRIES, LTD.
    • 15.19.1 COMPANY SNAPSHOT
    • 15.19.2 REVENUE ANALYSIS
    • 15.19.3 PRODUCT PORTFOLIO
    • 15.19.4 RECENT DEVELOPMENT
  • 15.20 VIEWRAY TECHNOLOGIES, INC. (A SUBSIDIARY OF VIEWRAY)
    • 15.20.1 COMPANY SNAPSHOT
    • 15.20.2 REVENUE ANALYSIS
    • 15.20.3 PRODUCT PORTFOLIO
    • 15.20.4 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 NORTH AMERICA CANCER INCIDENCE (2018)
  • TABLE 2 NORTH AMERICA CANCER INCIDENCE (2018)
  • TABLE 3 NORTH AMERICA CANCER INCIDENCE (2018)
  • TABLE 4 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
  • TABLE 5 PRODUCT CLASSIFICATION
  • TABLE 6 NORTH AMERICA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 7 NORTH AMERICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 NORTH AMERICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 9 NORTH AMERICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 NORTH AMERICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 11 NORTH AMERICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 12 NORTH AMERICA SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 NORTH AMERICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 15 NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 16 NORTH AMERICA DEVICES IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 NORTH AMERICA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 18 NORTH AMERICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19 NORTH AMERICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 20 NORTH AMERICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21 NORTH AMERICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 22 NORTH AMERICA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 23 NORTH AMERICA BREAST CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 24 NORTH AMERICA LUNG CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25 NORTH AMERICA PROSTATE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 26 NORTH AMERICA COLORECTAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 27 NORTH AMERICA LYMPHOMA IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 28 NORTH AMERICA LIVER CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29 NORTH AMERICA THYROID CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 30 NORTH AMERICA BRAIN CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 31 NORTH AMERICA CERVICAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 32 NORTH AMERICA SPINE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 33 NORTH AMERICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 34 NORTH AMERICA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 35 NORTH AMERICA HOSPITALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 36 NORTH AMERICA RADIATION THERAPY CENTERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 37 NORTH AMERICA SPECIALTY CLINICS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 38 NORTH AMERICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 39 NORTH AMERICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 40 NORTH AMERICA DIRECT TENDER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 41 NORTH AMERICA RETAIL SALES IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 42 NORTH AMERICA OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 43 NORTH AMERICA RADIOTHERAPY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 44 NORTH AMERICA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 NORTH AMERICA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 46 NORTH AMERICA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 47 NORTH AMERICA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 48 NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 49 NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 50 NORTH AMERICA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 51 NORTH AMERICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 52 NORTH AMERICA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 53 NORTH AMERICA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 54 NORTH AMERICA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 55 NORTH AMERICA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 56 U.S. RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 U.S. EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 58 U.S. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 59 U.S. BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60 U.S. RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 61 U.S. RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 62 U.S. EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 63 U.S. INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 64 U.S. RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 65 U.S. RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 66 U.S. RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 67 U.S. RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 68 CANADA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 69 CANADA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 CANADA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 71 CANADA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 72 CANADA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 73 CANADA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 74 CANADA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 75 CANADA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 76 CANADA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 77 CANADA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 78 CANADA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 79 CANADA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 80 MEXICO RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 81 MEXICO EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 82 MEXICO INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 83 MEXICO BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 84 MEXICO RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 85 MEXICO RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 86 MEXICO EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 87 MEXICO INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 88 MEXICO RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 89 MEXICO RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 90 MEXICO RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 91 MEXICO RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
Back to Top